Lupus Laboratory Workup
A comprehensive lupus workup should include routine laboratory tests (CBC, serum creatinine, proteinuria, urinary sediment) and immunological tests (serum C3/C4, anti-dsDNA, anti-Ro/SSA, anti-La/SSB, antiphospholipid antibodies, anti-RNP) as these provide essential prognostic information for disease activity and organ involvement. 1
Initial Testing for Diagnosis
First-Line Testing
- Anti-Nuclear Antibody (ANA): The reference method is indirect immunofluorescence assay (IIFA) on HEp-2 cells 1
- Screening dilution typically 1:160
- Report should include pattern and highest dilution showing reactivity
- Sensitivity for SLE approaches 100%, but specificity is low
Second-Line Testing (if ANA positive)
Anti-double stranded DNA (anti-dsDNA):
Extractable Nuclear Antigens (ENA) panel:
- Anti-Ro/SSA: Associated with photosensitivity, subacute cutaneous lupus, neonatal lupus
- Anti-La/SSB: Often with Sjögren's features
- Anti-Sm: Highly specific for SLE
- Anti-RNP: Associated with mixed connective tissue disease
- Results should be reported separately for each antigen 1
Additional Immunological Testing
Complement levels:
- C3 and C4 (decreased in active disease)
- Anti-C1q antibodies (associated with nephritis)
Antiphospholipid antibodies:
- Lupus anticoagulant (LA): Requires specialized coagulation testing 1
- Anti-cardiolipin antibodies (IgG and IgM)
- Anti-β2 glycoprotein I antibodies
Routine Laboratory Tests
Complete Blood Count (CBC):
- Hemoglobin (anemia)
- White blood cell count (leukopenia)
- Platelet count (thrombocytopenia)
Renal Function Tests:
- Serum creatinine
- Urinalysis with microscopic examination
- Urine protein:creatinine ratio or 24-hour protein
- Estimated glomerular filtration rate (eGFR)
Inflammatory Markers:
- Erythrocyte sedimentation rate (ESR)
- C-reactive protein (CRP)
Organ-Specific Testing (as indicated)
Renal Assessment:
- Renal biopsy (if significant proteinuria, hematuria, or declining renal function)
Neurological Assessment:
- Brain MRI (for neuropsychiatric manifestations)
- Cerebrospinal fluid analysis
Monitoring Disease Activity
For ongoing monitoring of disease activity, the following tests are most valuable:
- Anti-dsDNA antibody levels
- Complement levels (C3/C4)
- Complete blood count
- Urinalysis and proteinuria quantification
- Serum creatinine
Clinical Pearls and Pitfalls
- Important caveat: ANA testing should only be performed in patients with unexplained involvement of two or more organ systems, not for nonspecific symptoms like fatigue 3, 4
- The odds ratio for flare in asymptomatic patients with elevated anti-dsDNA is 3.0 and with low C3 is 2.0 5
- For monitoring anti-dsDNA levels, use the same method consistently 1
- Lupus anticoagulant testing should be performed before starting anticoagulant therapy or after discontinuation 1
- No single laboratory test can reliably distinguish disease activity levels; combinations of tests provide better assessment 6
Special Considerations
- Pregnancy: Additional monitoring of anti-Ro/SSA, anti-La/SSB, and antiphospholipid antibodies is crucial due to risk of neonatal lupus, congenital heart block, and pregnancy complications 1
- Antiphospholipid syndrome: Requires testing for lupus anticoagulant, anti-cardiolipin, and anti-β2 glycoprotein I antibodies 1